MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?

J Cyst Fibros. 2005 Sep;4(3):205-7. doi: 10.1016/j.jcf.2005.05.014.

Abstract

Methicillin-resistant Staphylocosis aureus (MRSA) is an emerging infection in patients with cystic fibrosis (CF). MRSA may be a management dilemma for healthcare workers (HCWs) with CF. Eradication of MRSA with long-term rifampicin and fusidic acid can be achieved in patients with CF. We describe a case of recurrent MRSA infection in a HCW with CF. Molecular typing of the MRSA isolates supported re-infection rather than re-emergence of an earlier MRSA infection. Infection control advice for HCWs with CF who acquire MRSA remains controversial.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use*
  • Cystic Fibrosis / microbiology*
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Fusidic Acid / therapeutic use
  • Health Personnel*
  • Humans
  • Methicillin Resistance*
  • Rifampin / therapeutic use
  • Sputum / microbiology
  • Staphylococcal Infections / complications
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / isolation & purification*

Substances

  • Anti-Bacterial Agents
  • Fusidic Acid
  • Rifampin